Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study.

Güvenç, Kübra Karakoç; Fentoglu, Özlem; Calapoglu, Mustafa; Aksoy, Fatih; Orhan, Hikmet

Güvenç, Kübra Karakoç; Fentoglu, Özlem; Calapoglu, Mustafa; Aksoy, Fatih; Orhan, Hikmet.

Afiliação

Güvenç KK; Faculty of Dentistry, Department of Periodontology, Süleyman Demirel University, Isparta, Turkey.
Fentoglu Ö; Faculty of Dentistry, Department of Periodontology, Süleyman Demirel University, Isparta, Turkey. ofentoglu@yahoo.com.
Calapoglu M; Faculty of Science, Department of Biochemistry, Süleyman Demirel University, Isparta, Turkey.
Aksoy F; Faculty of Medicine, Department of Cardiology, Süleyman Demirel University, Isparta, Turkey.
Orhan H; Faculty of Medicine, Department of Biostatistics, Süleyman Demirel Üniversitesi, Isparta, Turkey.

Clin Oral Investig ; 27(9): 5549-5558, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37535198

Assuntos

Doenças Cardiovasculares; Doenças Periodontais; Humanos; Qualidade de Vida; Inflamação; Ácido Eicosapentaenoico

Palavras-chave

Cardiovascular disease; Periodontal disease; Periodontal treatment; Specialized pro-resolving lipid molecules

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Periodontais / Doenças Cardiovasculares Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google